Mylan adds generic Detrol, HIV/AIDS drugs
By Alex Nixon
Published: Thursday, November 29, 2012, 12:40 p.m.
Updated: Tuesday, February 19, 2013
Mylan Inc. said on Thursday that it had introduced a generic incontinence drug to the U.S. market and was selected by the South African government as a supplier of antiretroviral drugs.
Cecil-based Mylan has started selling Tolterodine Tartrate tablets, the generic version of Detrol, made by Pfizer Inc. Tolterodine Tartrate had U.S. sales of $61.5 million for the 12 months ended Sept. 30.
The company said the South African National Department of Health selected Mylan's Indian subsidiary to supply it with 31 percent of the 30 million units of HIV/AIDS drugs it will buy in a two-year period ending Dec. 31, 2014.
Mylan's share of the contract is valued at about $127.5 million.
- ‘We did it!’ Peduto tells city, as he defeats Wagner
- Steelers’ Polamalu trim, fit as he arrives for OTAs
- Penguins Insider: Time is right for Jokinen’s return
- Neal’s solid play soon could pay off on scoresheet for Penguins
- Rupert wins Democratic nod to run for sheriff
- Kovacevic: Pens improve under microscope
- Senators get vote of confidence
- Steelers quarterback Roethlisberger likes the revamped offense
- Lincoln takes primary
- Mt. Pleasant mayor victorious
- Smeltzer loses seat on ASD board
You must be signed in to add comments
To comment, click the Sign in or sign up at the very top of this page.
Subscribe today! Click here for our subscription offers.